Rhenman & Partners Asset Management Ab Boston Scientific Corp Transaction History
Rhenman & Partners Asset Management Ab
- $766 Million
- Q2 2025
A detailed history of Rhenman & Partners Asset Management Ab transactions in Boston Scientific Corp stock. As of the latest transaction made, Rhenman & Partners Asset Management Ab holds 296,000 shares of BSX stock, worth $29.3 Million. This represents 4.15% of its overall portfolio holdings.
Number of Shares
296,000
Previous 300,000
1.33%
Holding current value
$29.3 Million
Previous $30.3 Million
5.05%
% of portfolio
4.15%
Previous 3.6%
Shares
30 transactions
Others Institutions Holding BSX
# of Institutions
1,935Shares Held
1.27BCall Options Held
9.55MPut Options Held
7.11M-
Vanguard Group Inc Valley Forge, PA137MShares$13.6 Billion0.25% of portfolio
-
Black Rock Inc. New York, NY126MShares$12.5 Billion0.22% of portfolio
-
State Street Corp Boston, MA65.2MShares$6.44 Billion0.27% of portfolio
-
Primecap Management CO Pasadena, CA34.7MShares$3.43 Billion3.04% of portfolio
-
Bank Of America Corp Charlotte, NC33.8MShares$3.35 Billion0.27% of portfolio
About BOSTON SCIENTIFIC CORP
- Ticker BSX
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,431,609,984
- Market Cap $142B
- Description
- Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...